STOCK TITAN

Viavi Solutions (VIAV) 424B Filings

VIAV NASDAQ

Here are the 424B prospectus supplements from Viavi Solutions Inc. (VIAV) in our archive over the last 12 months, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A 424B covers the supplement that carries the terms of a priced offering, so if you follow VIAV and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full VIAV filings page.

Rhea-AI Summary

Viavi Solutions is offering 11,111,111 shares of common stock pursuant to this prospectus supplement. The offering price is $45.00 per share for total gross proceeds of $499,999,995, with underwriters’ discounts of $1.35 per share. We estimate net proceeds to us of approximately $484.4 million, which we currently intend to use to repay the $450 million aggregate principal amount of our Term Loan B. The underwriters have an option to purchase up to 1,666,666 additional shares within 30 days.

Shares outstanding were 233,907,870 as of April 25, 2026; the prospectus shows common stock to be outstanding immediately after this offering of 245,018,981 shares (or 246,685,647 shares if the underwriters’ option is exercised in full). The prospectus supplement also presents March 28, 2026 cash and capitalization as adjusted to reflect the offering and application of net proceeds.

Rhea-AI Summary

Viavi Solutions Inc. is offering common stock with an aggregate public offering price of $500,000,000. This prospectus supplement is preliminary and subject to completion, dated May 19, 2026. The underwriters have a 30-day option to purchase additional shares with an aggregate public offering price of up to $75,000,000. The company states estimated net proceeds will be used to repay the $450 million aggregate principal amount of its 7-year Term Loan B entered into in October 2025; any excess will be used for working capital and general corporate purposes. Shares outstanding were 233,907,870 as of April 25, 2026. The offering assumes no exercise of the underwriters' option unless noted.